GeneNews to Raise C$7.7M in Private Placement | GenomeWeb

NEW YORK (GenomeWeb News) – GeneNews today said that it expects to raise gross proceeds of C$7.7 million (US$7.8 million) through a private placement of its common shares.

The Toronto-based molecular diagnostics developer said that it has accepted subscriptions for a non-brokered private placement of its shares. The firm said that the offering will result in the issuance of around 86.3 million common shares from treasury at a price of C$.09 per share.

GeneNews noted that the size of offering was increased from an initial C$6 million target "due to strong demand."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.